Sionna Therapeutics Inc

Fitzpatrick’s $6.11 buy of 10,250 Sionna shares signals cautious insider confidence amid broader sell‑offs, offering investors a subtle bullish hint.

TPG GP A, LLC sells 250,000 Sionna shares at $40 each – a subtle liquidity move that signals caution for investors watching Phase‑2 trials and future capital raises.

TPG GP A, LLC sells 250k Sionna shares at $40—an ordinary portfolio shuffle that leaves the biotech’s long‑term outlook unchanged and its stock steady near a 52‑week high.